Buscar

On 14 July 2022, the European Commission tabled a proposal to update and expand EU legislation on blood, tissues and cells. The aim is to establish high standards of quality and safety for substances of human origin (SoHOs) intended for human application, to improve the protection of donors, recipients, and offspring born from medically assisted reproduction, and to ensure that the legislation can respond to future challenges. The European Parliament's Committee on the Environment, Public Health ...

Durante su período parcial de sesiones de septiembre, está previsto que el Parlamento someta a votación el informe aprobado por la Comisión de Medio Ambiente, Salud Pública y Seguridad Alimentaria sobre una propuesta de revisión de la legislación de la Unión relativa a la sangre, los tejidos y las células. La propuesta representa un nuevo paso hacia la construcción de una Unión Europea de la Salud fuerte. El informe resultante de la votación constituirá la posición del Parlamento en las negociaciones ...

Regenerative medicine (RM) is an interdisciplinary field that applies engineering and life science techniques to restore tissues and organs damaged by age, disease or trauma, as well as those with congenital defects. Promising data supports the future capability of using RM across a wide array of organ systems and contexts, including surface wounds, cardiovascular diseases and traumas and treatments for certain types of cancer.

Organoids are artificially grown organs that mimic the properties of real organs. What new possibilities for treating diseases, drug development, and personalised and regenerative medicine do organoids provide?

This report summarises the presentations and discussions at the Workshop on Stem Cell Research and Patenting, held at the European Parliament in Brussels, on Monday 19 March 2012. The aim of the workshop was to better understand the scientific and legal issues surrounding stem cell research and patenting, in particular to improve awareness about the recent judgement of the Court of Justice of the European Union. The workshop was co-chaired by MEPs Glenis Willmott and Alojz Peterle.

This report summarises the presentations and discussions at the Workshop on Voluntary and Unpaid Donation of Tissues and Cells held at the European Parliament in Brussels on Tuesday 20 December 2011. The aim of the workshop was to gather input from specialists in different fields related to tissues and cell donation in order to learn more from their work and perspectives. The workshop was chaired by Marina YANNAKOUDAKIS, MEP.

Human embryo research is a well established feature of the modern scientific landscape. The technique has recently come to the fore in public policy debates because of new technological advances. Human embryo research now promises to play a pivotal role in the treatment of many chronic illnesses through developments in stem cell technology as well as continuing to offer hope for those who suffer from subfertility. Developments in the field of human stem cell research are, to a large degree, dependent ...